Mateon Therapeutics Acquires PointR Data Inc.

November 4, 2019

Mateon Therapeutics, Inc. (OTCQB:MATN) has completed its acquisition of PointR Data Inc., a revenue-generating AI and high-performance cluster computing company that provides AI Vision and blockchain solutions for pharmaceutical manufacturing and clinical trial monitoring. The deal brings PointR's leadership (including Saran Saund and Burcak Beser) into Mateon's management team and is intended to expand Mateon's capabilities by integrating AI and blockchain into its drug development, manufacturing and real-world evidence efforts.

Buyers
Mateon Therapeutics, Inc.
Targets
PointR Data Inc.
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.